Literature DB >> 32970194

Validation and comparison of prognostic values of GNRI, PNI, and CONUT in newly diagnosed diffuse large B cell lymphoma.

Toshihiro Matsukawa1, Keito Suto2,3, Minoru Kanaya4, Koh Izumiyama4, Koichiro Minauchi3, Shota Yoshida2, Hisashi Oda2, Takuto Miyagishima2, Akio Mori4, Shuichi Ota3, Daigo Hashimoto5, Takanori Teshima5.   

Abstract

Diffuse large B cell lymphoma (DLBCL) is the most common type of aggressive non-Hodgkin lymphoma. Emerging evidence indicates that poor nutritional status determined with nutritional indices such as geriatric nutritional risk index (GNRI), prognostic nutritional index (PNI), and controlling nutritional status score (CONUT) was associated with poor prognosis of DLBCL. We conducted this multicenter retrospective study to validate and compare prognostic values of the three indices in 615 newly diagnosed DLBCL patients. The overall survival (OS) in patients with poor nutritional status determined with each of these nutritional indices were significantly inferior compared with that in those without nutritional risks (5-year OS in patients with GNRI < 95.7 and GNRI ≥ 95.7 were 56.4% and 83.5%, P < 0.001; PNI < 42.4 and PNI ≥ 42.4 were 56.1% and 81.0%, P < 0.001; CONUT > 4 and CONUT ≤ 4 were 53.1% and 77.1%, P < 0.001). GNRI and CONUT were independent prognostic predictors for OS (GNRI < 95.7, hazard ratio [HR] 1.83, 95% confidence interval [CI] 1.22-2.74, P = 0.0032; CONUT > 4, HR 1.53, 95% CI 1.05-2.23, P = 0.028) after multivariate analyses. Nutritional status determined with GNRI affected OS more strongly in the patients with nongerminal center B cell-like (nonGCB) DLBCL compared with that in those with GCB-type DLBCL. In conclusion, baseline poor nutritional status determined based on GNRI or CONUT was an independent risk factor of newly diagnosed DLBCL, and GNRI was also useful as an independent prognostic factor for patients with nonGCB-type DLBCL.

Entities:  

Keywords:  Controlling nutritional status score; Diffuse large B cell lymphoma; Geriatric nutritional risk index; Nutrition; Prognostic nutritional index

Mesh:

Year:  2020        PMID: 32970194     DOI: 10.1007/s00277-020-04262-5

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  34 in total

1.  Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E-IPI).

Authors:  Ranjana H Advani; Haiyan Chen; Thomas M Habermann; Vicki A Morrison; Edie A Weller; Richard I Fisher; Bruce A Peterson; Randy D Gascoyne; Sandra J Horning
Journal:  Br J Haematol       Date:  2010-10       Impact factor: 6.998

2.  CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.

Authors:  Bertrand Coiffier; Eric Lepage; Josette Briere; Raoul Herbrecht; Hervé Tilly; Reda Bouabdallah; Pierre Morel; Eric Van Den Neste; Gilles Salles; Philippe Gaulard; Felix Reyes; Pierre Lederlin; Christian Gisselbrecht
Journal:  N Engl J Med       Date:  2002-01-24       Impact factor: 91.245

3.  Effect of nutritional status on survival outcome of diffuse large B-cell lymphoma patients treated with rituximab-CHOP.

Authors:  Silvia Park; Boram Han; Jae Won Cho; Sook-Young Woo; Seonwoo Kim; Seok Jin Kim; Won Seog Kim
Journal:  Nutr Cancer       Date:  2014-01-09       Impact factor: 2.900

4.  CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.

Authors:  Michael Pfreundschuh; Lorenz Trümper; Anders Osterborg; Ruth Pettengell; Marek Trneny; Kevin Imrie; David Ma; Devinder Gill; Jan Walewski; Pier-Luigi Zinzani; Rolf Stahel; Stein Kvaloy; Ofer Shpilberg; Ulrich Jaeger; Mads Hansen; Tuula Lehtinen; Armando López-Guillermo; Claudia Corrado; Adriana Scheliga; Noel Milpied; Myriam Mendila; Michelle Rashford; Evelyn Kuhnt; Markus Loeffler
Journal:  Lancet Oncol       Date:  2006-05       Impact factor: 41.316

5.  Serum albumin level at diagnosis of diffuse large B-cell lymphoma: an important simple prognostic factor.

Authors:  Osnat Bairey; Adi Shacham-Abulafia; Ofer Shpilberg; Ronit Gurion
Journal:  Hematol Oncol       Date:  2015-06-05       Impact factor: 5.271

Review 6.  Genetic alterations and their clinical implications in DLBCL.

Authors:  Yi Miao; L Jeffrey Medeiros; Yong Li; Jianyong Li; Ken H Young
Journal:  Nat Rev Clin Oncol       Date:  2019-10       Impact factor: 66.675

7.  Treatment results of aggressive B non-Hodgkin's lymphoma in advanced age considering comorbidity.

Authors:  Ruth Sonnen; Wolf-Peter Schmidt; Rolf Kuse; Norbert Schmitz
Journal:  Br J Haematol       Date:  2002-12       Impact factor: 6.998

8.  The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP.

Authors:  Laurie H Sehn; Brian Berry; Mukesh Chhanabhai; Catherine Fitzgerald; Karamjit Gill; Paul Hoskins; Richard Klasa; Kerry J Savage; Tamara Shenkier; Judy Sutherland; Randy D Gascoyne; Joseph M Connors
Journal:  Blood       Date:  2006-11-14       Impact factor: 22.113

9.  Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell-lymphoma.

Authors:  Maria Christina Cox; Italo Nofroni; Luigi Ruco; Rachele Amodeo; Antonella Ferrari; Giacinto La Verde; Patrizia Cardelli; Enrico Montefusco; Esmeralda Conte; Bruno Monarca; Maria Antonietta Aloe-Spiriti
Journal:  Leuk Lymphoma       Date:  2008-09

10.  An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era.

Authors:  Zheng Zhou; Laurie H Sehn; Alfred W Rademaker; Leo I Gordon; Ann S Lacasce; Allison Crosby-Thompson; Ann Vanderplas; Andrew D Zelenetz; Gregory A Abel; Maria A Rodriguez; Auayporn Nademanee; Mark S Kaminski; Myron S Czuczman; Michael Millenson; Joyce Niland; Randy D Gascoyne; Joseph M Connors; Jonathan W Friedberg; Jane N Winter
Journal:  Blood       Date:  2013-11-21       Impact factor: 22.113

View more
  7 in total

1.  Assessment of Systemic Inflammation and Nutritional Indicators in Predicting Recurrence-Free Survival After Surgical Resection of Gastrointestinal Stromal Tumors.

Authors:  Zhenhua Lu; Rui Li; Xianglong Cao; Chengyu Liu; Zhen Sun; Xiaolei Shi; Weiwei Shao; Yangyang Zheng; Jinghai Song
Journal:  Front Oncol       Date:  2021-07-26       Impact factor: 6.244

Review 2.  Long-term and short-term prognostic value of the prognostic nutritional index in cancer: a narrative review.

Authors:  Li Yan; Tomoki Nakamura; Andrea Casadei-Gardini; Gema Bruixola; Yuan-Lan Huang; Zhi-De Hu
Journal:  Ann Transl Med       Date:  2021-11

3.  CONUT Score: A New Tool for Predicting Prognosis in Patients with Advanced Thyroid Cancer Treated with TKI.

Authors:  Cristina Dalmiglio; Lucia Brilli; Michele Campanile; Cristina Ciuoli; Alessandra Cartocci; Maria Grazia Castagna
Journal:  Cancers (Basel)       Date:  2022-01-30       Impact factor: 6.639

4.  Three Nutritional Indices Are Effective Predictors of Mortality in Patients With Type 2 Diabetes and Foot Ulcers.

Authors:  Jing Hong; Qi-Qi Huang; Wen-Yue Liu; Xiang Hu; Fei-Fei Jiang; Ze-Ru Xu; Fei-Xia Shen; Hong Zhu
Journal:  Front Nutr       Date:  2022-03-15

Review 5.  Host-related factors and cancer: Malnutrition and non-Hodgkin lymphoma.

Authors:  Salvatrice Mancuso; Marta Mattana; Marco Santoro; Melania Carlisi; Silvio Buscemi; Sergio Siragusa
Journal:  Hematol Oncol       Date:  2022-04-18       Impact factor: 4.850

6.  Is CONUT score a prognostic index in patients with diffuse large cell lymphoma?

Authors:  Gülsüm Akgün Çağlıyan; Sibel Hacıoğlu; Başak Ünver Koluman; Kadir İlkkılıç; Rukiye Nar; Mehmet Nuri Başer; Aslı Bozdemir; Hande Şenol; Nilay Şen Türk; Veysel Erol; Onurcan Yılıdırım; Ömer Çağlıyan; Nil Güler
Journal:  Turk J Med Sci       Date:  2021-08-30       Impact factor: 0.973

7.  Prognostic Value of the Geriatric Nutritional Risk Index in Non-Small Cell Lung Cancer Patients: A Systematic Review and Meta-Analysis.

Authors:  Haoyu Wang; Cui Li; Ruiyuan Yang; Jing Jin; Dan Liu; Weimin Li
Journal:  Front Oncol       Date:  2022-01-18       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.